Loomba R, Sanyal AJ (2013) The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10:686–690

Article  CAS  PubMed  Google Scholar 

Terai S, Buchanan-Hughes A, Ng A et al (2021) Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database. J Gastroenterol 56:274–284

Article  PubMed  PubMed Central  Google Scholar 

Hyysalo J, Männistö VT, Zhou Y et al (2014) A population-based study on the prevalence of NASH using scores validated against liver histology. J Hepatol 60:839–846

Article  PubMed  Google Scholar 

Kleiner DE, Makhlouf HR (2016) Histology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults and children. Clin Liver Dis 20:293–312

Article  PubMed  Google Scholar 

Younossi ZM, Golabi P, de Avila L et al (2019) The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol 71:793–801

Article  PubMed  Google Scholar 

Eddowes PJ, Sasso M, Allison M et al (2019) Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 156:1717–1730

Article  PubMed  Google Scholar 

Imajo K, Kessoku T, Honda Y et al (2016) Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology 150:626–637

Article  PubMed  Google Scholar 

Selvaraj EA, Mózes FE, Jayaswal ANA et al (2021) Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis. J Hepatol 75:770–785

Article  PubMed  Google Scholar 

Dzyubak B, Li J, Chen J et al (2021) Automated analysis of multiparametric magnetic resonance imaging/magnetic resonance elastography exams for prediction of nonalcoholic steatohepatitis. J Magn Reson Imaging 54:122–131

Article  PubMed  PubMed Central  Google Scholar 

Troelstra MA, Witjes JJ, van Dijk AM et al (2021) Assessment of imaging modalities against liver biopsy in nonalcoholic fatty liver disease: the Amsterdam NAFLD-NASH cohort. J Magn Reson Imaging 54:1937–1949

Article  PubMed  PubMed Central  Google Scholar 

Imajo K, Tetlow L, Dennis A et al (2021) Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort. World J Gastroenterol 27:609–623

Article  PubMed  PubMed Central  Google Scholar 

Andersson A, Kelly M, Imajo K et al (2022) Clinical utility of magnetic resonance imaging biomarkers for identifying nonalcoholic steatohepatitis patients at high risk of progression: a multicenter pooled data and meta-analysis. Clin Gastroenterol Hepatol 20:2451–2461

Article  PubMed  Google Scholar 

Nascimbeni F, Bedossa P, Fedchuk L et al (2020) Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease. J Hepatol 72:828–838

Article  CAS  PubMed  Google Scholar 

Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321

Article  PubMed  Google Scholar 

Imajo K, Kessoku T, Honda Y et al (2022) MRI-based quantitative R2* mapping at 3 Tesla reflects hepatic iron overload and pathogenesis in nonalcoholic fatty liver disease patients. J Magn Reson Imaging 55:111–125

Article  PubMed  Google Scholar 

Bedossa P, Poitou C, Veyrie N et al (2012) Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 56:1751–1759

Article  PubMed  Google Scholar 

Sandrin L, Fourquet B, Hasquenoph JM et al (2003) Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29:1705–1713

Article  PubMed  Google Scholar 

Newsome PN, Sasso M, Deeks JJ et al (2020) FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol 5:362–373

Article  PubMed  PubMed Central  Google Scholar 

Yin M, Talwalkar JA, Glaser KJ et al (2007) Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5:1207–1213

Article  PubMed  PubMed Central  Google Scholar 

Chen J, Talwalkar JA, Yin M et al (2011) Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 259:749–756

Article  PubMed  PubMed Central  Google Scholar 

Campo CA, Hernando D, Schubert T et al (2017) Standardized approach for ROI-based measurements of proton density fat fraction and R2* in the liver. AJR Am J Roentgenol 209:592–603

Article  PubMed  PubMed Central  Google Scholar 

Banerjee R, Pavlides M, Tunnicliffe EM et al (2014) Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol 60:69–77

Article  PubMed  PubMed Central  Google Scholar 

Noureddin M, Truong E, Gornbein JA et al (2022) MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis. J Hepatol 76:781–787

Article  PubMed  Google Scholar 

Tamaki N, Imajo K, Sharpton S et al (2022) Magnetic resonance elastography plus fibrosis-4 versus FibroScan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosis. Hepatology 75:661–672

Article  CAS  PubMed  Google Scholar 

Bernau C, Riester M, Boulesteix A-L et al (2014) Cross-study validation for the assessment of prediction algorithms. Bioinformatics 30:105–112

Article  Google Scholar 

Oeda S, Takahashi H, Imajo K et al (2020) Diagnostic accuracy of FibroScan-AST score to identify non-alcoholic steatohepatitis with significant activity and fibrosis in Japanese patients with non-alcoholic fatty liver disease: comparison between M and XL probes. Hepatol Res 50:831–839

Article  CAS  PubMed  Google Scholar 

Kim BK, Tamaki N, Imajo K et al (2022) Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD. J Hepatol 77:1482–1490

Article  PubMed  Google Scholar 

Tamaki N, Munaganuru N, Jung J (2021) Clinical utility of change in nonalcoholic fatty liver disease activity score and change in fibrosis in NAFLD. Clin Gastroenterol Hepatol 19:2673–2674

Article  PubMed  Google Scholar 

Harrison SA (2015) Nonalcoholic fatty liver disease and fibrosis progression: the good, the bad, and the unknown. Clin Gastroenterol Hepatol 13:655–657

Article  PubMed  Google Scholar